Division of Gynaecologic Oncology, Department of Obstetrics and Gynaecology, University Hospitals Leuven, Katholieke Universiteit Leuven, Leuven, Belgium.
Eur J Cancer. 2011 Jan;47(2):191-8. doi: 10.1016/j.ejca.2010.08.020. Epub 2010 Sep 27.
AIMS OF THE STUDY AND METHODS: Survival, complications and recurrences after diaphragmatic surgery at primary or interval debulking surgery were compared. One hundred and sixty three consecutive patients with stage III/IV ovarian cancer underwent diaphragmatic surgery between September 1993 and December 2007. Primary debulking was performed in group 1 (89) patients and interval debulking was performed in group 2 (74) patients. Cytoreductive outcome, overall survival (OS), disease-free survival (DFS) and post-operative complications were analysed.
Despite differences in baseline mean age (p=0.015), in FIGO stage III/IV (p=0.036) and in mean largest diameter of metastatic disease at the beginning of debulking surgery (p=0.037), the optimal debulking rates (residual tumour less than 1cm) were similar (p=0.065). Excision of diaphragmatic metastases was most frequently performed in group 1 (77.53%) and coagulation was most frequently performed in group 2 (58.10%). Similar overall survival and disease-free survival rates were found. After the propensity matching procedure, the largest diameter of metastatic disease at the time of debulking and no residual tumour (complete debulking) were demonstrated as independent prognostic factors for OS. Plaque-like lesions on the diaphragm metastases were significantly (p=0.015) more associated with diaphragm recurrence than papillary lesions. Minor and major complications related to diaphragmatic surgery as well as mean operating time, post-operative care in intensive care unit and length of hospitalisation were significantly higher in group 1 rather than in group 2 (p=0.043).
Diaphragmatic dissemination resulted in similar survival and cytoreductive rates after primary and interval debulking. However, the morbidity was less after interval debulking as fewer surgical procedures were performed.
研究目的和方法:比较原发性或间隔性减瘤术后膈肌手术的生存率、并发症和复发率。1993 年 9 月至 2007 年 12 月,163 例 III/IV 期卵巢癌患者连续行膈肌手术。89 例患者行原发性减瘤术(第 1 组),74 例患者行间隔性减瘤术(第 2 组)。分析减瘤术结果、总生存率(OS)、无病生存率(DFS)和术后并发症。
尽管两组患者的基线平均年龄(p=0.015)、FIGO 分期 III/IV(p=0.036)和减瘤术开始时转移性疾病的最大直径平均值(p=0.037)存在差异,但最佳减瘤率(残余肿瘤小于 1cm)相似(p=0.065)。第 1 组(77.53%)最常切除膈肌转移灶,第 2 组(58.10%)最常行凝固术。两组的总生存率和无病生存率相似。在倾向匹配程序后,减瘤术时转移性疾病的最大直径和无肿瘤残留(完全减瘤)被证明是 OS 的独立预后因素。膈肌转移灶的斑块样病变与膈肌复发显著相关(p=0.015),而乳头状病变无显著相关性。第 1 组与膈肌手术相关的轻微和严重并发症、平均手术时间、重症监护病房的术后护理和住院时间均明显高于第 2 组(p=0.043)。
原发性和间隔性减瘤术后膈肌播散的生存率和减瘤率相似。然而,由于手术次数较少,间隔性减瘤的发病率较低。